famotidine has been researched along with Gastric Fistula in 4 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Gastric Fistula: Abnormal passage communicating with the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The duration of intragastric pH-elevation upon administration of the novel H+K(+)-ATPase inhibitor pantoprazole and its pharmacodynamic interaction with H2 receptor blockade was assessed in the gastric fistula dog using the intragastric 24 hour pH-metry." | 7.68 | The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog. ( Bräuer, U; Kromer, W; Postius, S, 1991) |
| "The duration of intragastric pH-elevation upon administration of the novel H+K(+)-ATPase inhibitor pantoprazole and its pharmacodynamic interaction with H2 receptor blockade was assessed in the gastric fistula dog using the intragastric 24 hour pH-metry." | 3.68 | The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog. ( Bräuer, U; Kromer, W; Postius, S, 1991) |
| " The YM022 dosage required to inhibit basal acid secretion is consistent with that required to suppress pentagastrin-induced acid secretion." | 1.29 | Comparative evaluation of the role of endogenous gastrin in basal acid secretion in conscious rats provided with chronic fistula and pylorus ligation. ( Akuzawa, S; Miyata, K; Nishida, A; Takemoto, Y; Uchida-Kobayashi, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krylova, SG | 1 |
| Vymyatnina, ZK | 1 |
| Zueva, EP | 1 |
| Amosova, EN | 1 |
| Razina, TG | 1 |
| Litvinenko, VI | 1 |
| Pendleton, RG | 1 |
| Torchiana, ML | 1 |
| Chung, C | 1 |
| Cook, P | 1 |
| Wiese, S | 1 |
| Clineschmidt, BV | 1 |
| Nishida, A | 1 |
| Uchida-Kobayashi, A | 1 |
| Takemoto, Y | 1 |
| Akuzawa, S | 1 |
| Miyata, K | 1 |
| Postius, S | 1 |
| Bräuer, U | 1 |
| Kromer, W | 1 |
4 other studies available for famotidine and Gastric Fistula
| Article | Year |
|---|---|
Effects of Cichorium Intybus L. Root Extract on Secretory Activity of the Stomach in Health and Ulcer Disease.
Topics: Animals; Anti-Ulcer Agents; Carbachol; Cichorium intybus; Dogs; Famotidine; Female; Gastric Fistula; | 2015 |
Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
Topics: Animals; Cimetidine; Famotidine; Female; Gastric Acid; Gastric Fistula; Guinea Pigs; Heart Atria; He | 1983 |
Comparative evaluation of the role of endogenous gastrin in basal acid secretion in conscious rats provided with chronic fistula and pylorus ligation.
Topics: Animals; Atropine; Benzodiazepines; Chronic Disease; Famotidine; Gastric Acid; Gastric Fistula; Gast | 1996 |
The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Dogs; F | 1991 |